Learn more

FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE NAUCHNOE UCHREZHDENIE INST EKSPERIMENTALNOJ MEDITSINY FGBNU I

Overview
  • Total Patents
    30
  • GoodIP Patent Rank
    54,068
  • Filing trend
    ⇧ 16.0%
About

FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE NAUCHNOE UCHREZHDENIE INST EKSPERIMENTALNOJ MEDITSINY FGBNU I has a total of 30 patent applications. It increased the IP activity by 16.0%. Its first patent ever was published in 2015. It filed its patents most often in Russian Federation. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are UNIVERSITAETSKLINIKUM JENA, JIANGSU NANNONG HI TECH CO LTD and SHANGHAI VETERINARY RES INST CHINESE ACADEMY AGRICULTURAL SCIENCES CHINA CT ANIMAL.

Patent filings in countries

World map showing FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE NAUCHNOE UCHREZHDENIE INST EKSPERIMENTALNOJ MEDITSINY FGBNU Is patent filings in countries
# Country Total Patents
#1 Russian Federation 30

Patent filings per year

Chart showing FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE NAUCHNOE UCHREZHDENIE INST EKSPERIMENTALNOJ MEDITSINY FGBNU Is patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Rudenko Larisa Georgievna 11
#2 Kiseleva Irina Vasilevna 9
#3 Bazhenova Ekaterina Andreevna 8
#4 Krutikova Elena Vitalevna 8
#5 Larionova Natalya Valentinovna 6
#6 Stepanova Ekaterina Alekseevna 6
#7 Suvorov Aleksandr Nikolaevich 5
#8 Isakova-Sivak Irina Nikolaevna 5
#9 Korzhevskij Dmitrij Eduardovich 4
#10 Gupalova Tatyana Vitalievna 3

Latest patents

Publication Filing date Title
RU2734718C1 Method of reducing manifestation of non-motor symptoms in patients with parkinson's disease
RU2735293C1 Method for assessing the reproductive activity of influenza viruses in a trivalent and quadrivalent live influenza vaccine
RU2735291C1 Vaccine strain of influenza virus a/17/brisbane/2018/8175 (h1n1) pdm09 for production of live influenza intranasal vaccine for adults and children
RU2732610C1 Vaccine strain of influenza a/17/kansas/2017/631 (h3n2) virus for production of live influenza intranasal vaccine for adults and children
RU2734897C1 Vaccine strain of influenza virus a/17/brisbane/2018/3610 (h3n2) for production of live influenza intranasal vaccine for adults and children
RU2719163C1 Method of antigen retrieval during immunocytochemical reactions
RU2716416C1 Reassortant strain of influenza virus rn2/14-human a(h6n2) for detecting neuraminidase antibodies in influenza infection and vaccination
RU2746274C2 Vaccine strain of influenza b/60/colorado/2017/1 (victoria line) for the production of live influenza intranasal vaccine for adults and children
RU2711101C1 Vaccine strain of influenza virus a/17/brisbane/2017/7178 (h3n2) for production of live influenza intranasal vaccine for adults and children
RU2715674C1 Vaccine strain of influenza virus a/17/switzerland/2017/51 (h3n2) for production of live influenza intranasal vaccine for adults and children
RU2746162C2 Method of transfection and cultivation of cells synthesizing recombinant protein - glutamic acid decarboxylase
RU2700576C1 Anxiolytic agent
RU2712017C1 Complex for synchronous registration of patient's physiological parameters and its position in three-dimensional space with dynamic postural effects
RU2705811C1 Method for detecting endothelial cells on histological preparations
RU2705810C1 Anticonvulsant
RU2734896C2 Method for preparing an autoprobiotic based on an anaerobic consortium of bacteria
RU2701733C1 Live vaccine based on enterococcus faecium l3 probiotic strain for prevention of infection caused by streptococcus pneumonie
RU2689791C1 Method for determining viability of human spermatozoa
RU2685121C1 Vaccine strain of influenza virus a/17/hongkong/2017/75108 (h7n9) for producing potentially pandemic live intranasal influenza vaccine
RU2683500C1 A/17/singapore/2016/3571 (h3n2) vaccine influenza strain for producing live influenza intranazal vaccine for adults and children